Stockscreener 앱 받기
59.86
8.67%
-5.20
전일 마감가:
$65.06
열려 있는:
$60
하루 거래량:
1.65M
Relative Volume:
0.68
시가총액:
$7.44B
수익:
$692.26M
순이익/손실:
$-512.41M
주가수익비율:
-14.12
EPS:
-4.24
순현금흐름:
$-274.36M
1주 성능:
-7.84%
1개월 성능:
+34.46%
6개월 성능:
+43.24%
1년 성능:
+144.01%
1일 변동 폭
$57.50
$61.48
1주일 범위
$57.50
$68.00
52주 변동 폭
$20.14
$68.00
가든트헬스 Stock (GH) Company Profile
명칭
Guardant Health Inc
전화
855-698-8887
주소
3100 HANOVER STREET, PALO ALTO
GH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
59.65 | 8.29B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
478.69 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
195.02 | 145.92B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
631.17 | 51.16B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
124.70 | 35.50B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
181.01 | 31.24B | 15.70B | 1.24B | 2.01B | 6.91 |
가든트헬스 Stock (GH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-01-23 | 개시 | Barclays | Overweight |
| 2024-06-28 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-24 | 재개 | Craig Hallum | Buy |
| 2023-12-14 | 개시 | Guggenheim | Neutral |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-11-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-27 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-26 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-03-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-11-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | 개시 | Craig Hallum | Buy |
| 2022-10-06 | 개시 | Stephens | Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-06-03 | 개시 | Piper Sandler | Overweight |
| 2022-04-28 | 재개 | BTIG Research | Buy |
| 2022-02-24 | 재확인 | Canaccord Genuity | Buy |
| 2022-02-24 | 재확인 | Citigroup | Buy |
| 2022-02-24 | 재확인 | Cowen | Outperform |
| 2022-02-24 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-24 | 재확인 | SVB Leerink | Outperform |
| 2022-02-24 | 재확인 | Stifel | Buy |
| 2022-02-24 | 재확인 | Wells Fargo | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-11 | 개시 | Stifel | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-06-12 | 개시 | BTIG Research | Buy |
| 2020-02-21 | 개시 | Guggenheim | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-08-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-16 | 개시 | Canaccord Genuity | Buy |
| 2019-04-10 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | 재확인 | BofA/Merrill | Neutral |
| 2018-10-29 | 개시 | BofA/Merrill | Neutral |
| 2018-10-29 | 개시 | JP Morgan | Overweight |
| 2018-10-29 | 개시 | William Blair | Outperform |
모두보기
가든트헬스 주식(GH)의 최신 뉴스
Liquid Biopsy in Cancer Diagnostics Market to Witness Robust ~17% CAGR Expansion by 2032 | DelveInsight - Barchart.com
Is Guardant Health Inc. stock ready for a breakoutPortfolio Performance Summary & Stepwise Trade Execution Plans - Newser
Analyzing recovery setups for Guardant Health Inc. investors2025 Top Gainers & Risk Managed Trade Strategies - Newser
How to recover losses in Guardant Health Inc. stockPortfolio Update Summary & Stepwise Swing Trade Plans - Newser
Multi asset correlation models including Guardant Health Inc.Options Play & Daily Profit Focused Stock Screening - Newser
Is Guardant Health Inc. showing signs of accumulationEarnings Summary Report & Entry Point Confirmation Alerts - Newser
Guardant Health Inc. stock daily chart insightsPortfolio Profit Report & Safe Capital Growth Tips - Newser
Is It Too Late to Sell Guardant Health Inc.2025 Big Picture & Daily Technical Forecast Reports - beatles.ru
Automated trading signals detected on Guardant Health Inc.Weekly Gains Report & Capital Efficiency Focused Strategies - Newser
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands - PR Newswire
Will Guardant Health Inc. stock split in the near futureMarket Weekly Review & Weekly Momentum Picks - Newser
Is GH's Q1 2025 forecast achievable? - AInvest
Advanced analytics toolkit walkthrough for Guardant Health Inc.Analyst Downgrade & Weekly Top Gainers Alerts - Newser
Cyted Health’s $44M Series B: A Strategic Bet on Early Cancer Detection and Global Expansion - AInvest
Liquid Biopsy Market Trends and Industry Forecast to 2030 - GlobeNewswire
Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others - Yahoo Finance
Will Guardant Health Inc. see short term momentumTrade Volume Summary & Growth Focused Stock Reports - Newser
What’s the analyst consensus on Guardant Health Inc.Rate Cut & Free Real-Time Market Sentiment Alerts - خودرو بانک
How to read the order book for Guardant Health Inc.Market Growth Report & Risk Managed Investment Entry Signals - Newser
Is Guardant Health Inc. impacted by rising ratesQuarterly Profit Review & Smart Money Movement Alerts - khodrobank.com
Will Guardant Health Inc. bounce back from current supportJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - Newser
What to do if you’re stuck in Guardant Health Inc.Portfolio Growth Summary & Capital Efficiency Focused Ideas - Newser
Live market analysis of Guardant Health Inc.Dividend Hike & Stepwise Swing Trade Plans - Newser
Signal strength of Guardant Health Inc. stock in tech scannersJuly 2025 Market Mood & High Yield Stock Recommendations - Newser
Guardant Health Inc. stock prediction for this weekTreasury Yields & Technical Analysis for Trade Confirmation - Newser
Using flow based indicators on Guardant Health Inc.Weekly Trend Summary & Risk Controlled Stock Pick Alerts - Newser
Will Guardant Health Inc. Bounce From 52 Week Low getLinesFromResByArray error: size == 0 - 더경남뉴스
Guardant Health Inc. stock outlook for YEARForecast Cut & Expert Curated Trade Setup Alerts - Newser
Will Guardant Health Inc. stock recover after recent drop2025 Support & Resistance & Long-Term Growth Stock Strategies - Newser
Guardant Health’s Strategic Moves and Analyst Confidence Propel Market Potential - StocksToTrade
Technical signs of recovery in Guardant Health Inc.2025 Retail Activity & Low Drawdown Trading Techniques - Newser
Can machine learning forecast Guardant Health Inc. recoveryEarnings Summary Report & Reliable Intraday Trade Alerts - Newser
Backtesting results for Guardant Health Inc. trading strategiesPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - Newser
Is Guardant Health Inc. stock showing strong momentumWeekly Trading Summary & Expert Approved Trade Ideas - sundaytimes.kr
가든트헬스 (GH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.53%
0.09%
자본화:
|
볼륨(24시간):